Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yangqiu Li

Showing results (1-10 of 291) with videos related to

Pageof 30
Sort By:
Hematology (Amsterdam, Netherlands)|October 16, 2008
Alterations in the expression pattern of TCR zeta chain in T cells from patients with hematological diseasesYangqiu Li
Hematology (Amsterdam, Netherlands)|December 12, 2003
Leukemia associated clonal expansion of TCR Vbeta subfamily T cellsYangqiu Li
Hematology (Amsterdam, Netherlands)|August 9, 2005
Recent thymic output function in patients with hematological malignancyYangqiu Li
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 13, 2003
[Advance of Research on Treatment of Donor Lymphocyte Infusions in Relapse of Hematologic Malignancies after Allogeneic Bone Marrow Transplantation]Rongfu Li, Yangqiu Li
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 13, 2003
The Role of Transcription Factor GATA-2 in Early HematopoiesisYangqiu Li, Mingchun Wang
Blood Science (Baltimore, Md.)|October 31, 2022
Immune checkpoint alterations and their blockade in COVID-19 patientsJiaxiong Tan, Yangqiu Li
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|June 4, 2019
Extensive exploration of T cell heterogeneity in cancers by single cell sequencingXiaofang Wang, Yangqiu Li
Stem Cell Investigation|July 1, 2016
Evaluation of TCR repertoire diversity in patients after hematopoietic stem cell transplantationYangqiu Li, Ling Xu
Cancer Cell International|January 10, 2019
T cell receptor-engineered T cells for leukemia immunotherapyYikai Zhang, Yangqiu Li
Cancer Cell International|February 12, 2013
The role of peptide and DNA vaccines in myeloid leukemia immunotherapyChen Lin, Yangqiu Li
Pageof 30

Showing results (1-10 of 291) with videos related to

Sort By:
Pageof 30
Hematology (Amsterdam, Netherlands)|October 16, 2008
Alterations in the expression pattern of TCR zeta chain in T cells from patients with hematological diseasesYangqiu Li
Hematology (Amsterdam, Netherlands)|December 12, 2003
Leukemia associated clonal expansion of TCR Vbeta subfamily T cellsYangqiu Li
Hematology (Amsterdam, Netherlands)|August 9, 2005
Recent thymic output function in patients with hematological malignancyYangqiu Li
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 13, 2003
[Advance of Research on Treatment of Donor Lymphocyte Infusions in Relapse of Hematologic Malignancies after Allogeneic Bone Marrow Transplantation]Rongfu Li, Yangqiu Li
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 13, 2003
The Role of Transcription Factor GATA-2 in Early HematopoiesisYangqiu Li, Mingchun Wang
Blood Science (Baltimore, Md.)|October 31, 2022
Immune checkpoint alterations and their blockade in COVID-19 patientsJiaxiong Tan, Yangqiu Li
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|June 4, 2019
Extensive exploration of T cell heterogeneity in cancers by single cell sequencingXiaofang Wang, Yangqiu Li
Stem Cell Investigation|July 1, 2016
Evaluation of TCR repertoire diversity in patients after hematopoietic stem cell transplantationYangqiu Li, Ling Xu
Cancer Cell International|January 10, 2019
T cell receptor-engineered T cells for leukemia immunotherapyYikai Zhang, Yangqiu Li
Cancer Cell International|February 12, 2013
The role of peptide and DNA vaccines in myeloid leukemia immunotherapyChen Lin, Yangqiu Li
Pageof 30